ES2852098T3 - Compuesto cíclico que actúa como inhibidor de PDE4 - Google Patents
Compuesto cíclico que actúa como inhibidor de PDE4 Download PDFInfo
- Publication number
- ES2852098T3 ES2852098T3 ES17842893T ES17842893T ES2852098T3 ES 2852098 T3 ES2852098 T3 ES 2852098T3 ES 17842893 T ES17842893 T ES 17842893T ES 17842893 T ES17842893 T ES 17842893T ES 2852098 T3 ES2852098 T3 ES 2852098T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- group
- mmol
- room temperature
- pmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CCc(c*1)cc*1F Chemical compound CCc(c*1)cc*1F 0.000 description 5
- RBRRRALIDXHNKP-GOSISDBHSA-N CCOC(c(cc1)cc(N2)c1N([C@H](CS(C)(=O)=O)c(cc1OCC)ccc1OC)C2=O)=O Chemical compound CCOC(c(cc1)cc(N2)c1N([C@H](CS(C)(=O)=O)c(cc1OCC)ccc1OC)C2=O)=O RBRRRALIDXHNKP-GOSISDBHSA-N 0.000 description 1
- SKXZZDHJQLRXSJ-GOSISDBHSA-N CCOc(cc([C@@H](CS(C)(=O)=O)N(c(cccc1-[n]2nccc2)c1N1)C1=O)cc1)c1OC Chemical compound CCOc(cc([C@@H](CS(C)(=O)=O)N(c(cccc1-[n]2nccc2)c1N1)C1=O)cc1)c1OC SKXZZDHJQLRXSJ-GOSISDBHSA-N 0.000 description 1
- PNETWKSJIDVOJS-OAHLLOKOSA-N CCOc1cc([C@@H](CS(C)(=O)=O)N(c(c(F)cc(C(F)(F)F)c2)c2N2)C2=O)ccc1OC Chemical compound CCOc1cc([C@@H](CS(C)(=O)=O)N(c(c(F)cc(C(F)(F)F)c2)c2N2)C2=O)ccc1OC PNETWKSJIDVOJS-OAHLLOKOSA-N 0.000 description 1
- OOFHEXZJUUUYCV-MRXNPFEDSA-N CCOc1cc([C@@H](CS(C)(=O)=O)N(c(ccc(C(O)=O)c2)c2N2)C2=O)ccc1OC Chemical compound CCOc1cc([C@@H](CS(C)(=O)=O)N(c(ccc(C(O)=O)c2)c2N2)C2=O)ccc1OC OOFHEXZJUUUYCV-MRXNPFEDSA-N 0.000 description 1
- PMZDDYGZGWORPV-MRXNPFEDSA-N CCOc1cc([C@@H](CS(C)(=O)=O)N(c(ccc(Cl)c2)c2N2)C2=O)ccc1OC Chemical compound CCOc1cc([C@@H](CS(C)(=O)=O)N(c(ccc(Cl)c2)c2N2)C2=O)ccc1OC PMZDDYGZGWORPV-MRXNPFEDSA-N 0.000 description 1
- OORBDHOQLZRIQR-UHFFFAOYSA-N Cc(cc1)cc([N+]([O-])=O)c1F Chemical compound Cc(cc1)cc([N+]([O-])=O)c1F OORBDHOQLZRIQR-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610706073 | 2016-08-22 | ||
| PCT/CN2017/098462 WO2018036470A1 (zh) | 2016-08-22 | 2017-08-22 | 作为pde4抑制剂的并环类化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2852098T3 true ES2852098T3 (es) | 2021-09-13 |
Family
ID=61246426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17842893T Active ES2852098T3 (es) | 2016-08-22 | 2017-08-22 | Compuesto cíclico que actúa como inhibidor de PDE4 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10532986B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3502099B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7050054B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN109563051B (cg-RX-API-DMAC10.html) |
| ES (1) | ES2852098T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2018036470A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7237973B2 (ja) * | 2018-01-29 | 2023-03-13 | メッドシャイン ディスカバリー インコーポレイテッド | 1H-イミダゾ[4,5-b]ピリジン-2(3H)-オン系化合物の結晶形及びその製造方法 |
| WO2021000934A1 (zh) * | 2019-07-04 | 2021-01-07 | 南京明德新药研发有限公司 | 一种苯并咪唑-2-酮类化合物的晶型、溶剂化物、溶剂化物的晶型及它们的制备方法 |
| EP4101848A4 (en) * | 2020-02-24 | 2023-07-26 | Suzhou Longbotai Pharmaceuticals Co., Ltd. | Pde4 inhibitor compound and medical use thereof |
| CN116783181B (zh) * | 2021-04-12 | 2026-01-30 | 上海瑛派药业有限公司 | 取代的稠合双环类化合物作为parp抑制剂及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002072576A1 (en) | 2001-03-09 | 2002-09-19 | Pfizer Products Inc. | Benzimidazole anti-inflammatory compounds |
| US7115644B2 (en) * | 2002-09-13 | 2006-10-03 | Boehringer Ingelheim Pharmaceuticals Inc. | Heterocyclic compounds |
| US8119676B2 (en) * | 2006-08-26 | 2012-02-21 | Abbott GmbH & Co. HG | Substituted benzimidazolone derivatives, medicaments comprising them and their use |
| WO2011021678A1 (ja) * | 2009-08-21 | 2011-02-24 | 武田薬品工業株式会社 | 縮合複素環化合物 |
| EP2603079B1 (en) * | 2010-08-12 | 2018-09-19 | Merck Sharp & Dohme Corp. | Positive allosteric modulators of mglur2 |
| MD20150071A2 (ro) | 2013-02-19 | 2016-02-29 | Pfizer Inc. | Compuşi azabenzimidazolici ca inhibitori ai PDE4 izoenzimelor pentru tratamentul tulburărilor SNC şi altor afecţiuni |
| KR102307566B1 (ko) * | 2013-06-21 | 2021-10-05 | 제니쓰 에피제네틱스 리미티드 | 신규한 바이사이클릭 브로모도메인 억제제 |
| JP2014114308A (ja) | 2014-01-31 | 2014-06-26 | Celgene Corp | (+)−2−[1−(3−エトキシ−4−メトキシフェニル)−2−メチルスルホニルエチル]−4−アセチルアミノイソインドリン−1,3−ジオンを含む固形物形態、その組成物およびその使用 |
| AR101196A1 (es) | 2014-07-16 | 2016-11-30 | Gruenenthal Gmbh | Compuestos de pirimidina sustituidos |
-
2017
- 2017-08-22 WO PCT/CN2017/098462 patent/WO2018036470A1/zh not_active Ceased
- 2017-08-22 CN CN201780046018.7A patent/CN109563051B/zh active Active
- 2017-08-22 JP JP2019510933A patent/JP7050054B2/ja active Active
- 2017-08-22 EP EP17842893.4A patent/EP3502099B1/en active Active
- 2017-08-22 US US16/325,626 patent/US10532986B2/en active Active
- 2017-08-22 ES ES17842893T patent/ES2852098T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3502099A4 (en) | 2020-03-04 |
| US10532986B2 (en) | 2020-01-14 |
| EP3502099B1 (en) | 2020-12-09 |
| JP7050054B2 (ja) | 2022-04-07 |
| CN109563051B (zh) | 2024-06-11 |
| US20190210975A1 (en) | 2019-07-11 |
| WO2018036470A1 (zh) | 2018-03-01 |
| JP2019529364A (ja) | 2019-10-17 |
| CN109563051A (zh) | 2019-04-02 |
| EP3502099A1 (en) | 2019-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7644517B2 (ja) | Kras突然変異型タンパク質阻害剤 | |
| ES2919474T3 (es) | Derivado de [1,2,4]triazolo[1,5-c]pirimidina como inhibidor del receptor A2A | |
| ES2870524T3 (es) | Derivado de piridina como inhibidor de ASK1, y método de preparación y uso del mismo | |
| EP3719012B1 (en) | N-[4-[(2-amino-4-pyridinyl)oxy]-3-fluorophenyl]-3-(4-fluorophenyl)-1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinecarboxamide derivatives as c-met/axl inhibitors for the treatment of tumors | |
| AU2019342102B2 (en) | Compounds for treating certain leukemias | |
| ES2746207T3 (es) | Derivado cristalino de 6,7-insaturado-7-carbamoilmorfinano y método de producción del mismo | |
| CN112839655B (zh) | 甲状腺激素受体β促效剂化合物 | |
| KR20240159579A (ko) | Parg 억제제 | |
| RU2743126C2 (ru) | Ингибитор pde4 | |
| ES2934432T3 (es) | Compuestos de imidazopirazina, métodos de preparación y usos de los mismos | |
| ES2984158T3 (es) | Inhibidores y moduladores de WDR5 | |
| ES2927086T3 (es) | Derivado de anillo condensado como inhibidor del receptor A2A | |
| CN116940581A (zh) | 一类新型蛋白降解剂及其应用 | |
| EP3502099B1 (en) | Cyclic compound acting as pde4 inhibitor | |
| EP4538274A1 (en) | Hpk1 inhibitor and medical use thereof | |
| ES3061587T3 (en) | Azaheteroaryl compound, preparation method therefor, and application thereof | |
| BR112016005361B1 (pt) | Composto, composição, e, uso de um composto | |
| CN111440146B (zh) | 一种具有par4拮抗活性的苯并三嗪类化合物及其应用 | |
| ES2882531T3 (es) | Compuesto anti-virus CMVH | |
| JP2022537415A (ja) | Fgfr4を阻害するための化合物 | |
| TWI894448B (zh) | Ctla-4小分子降解劑及其應用 | |
| CN121311480A (zh) | Lzk抑制剂 | |
| WO2023015240A1 (en) | Tricyclic fused pyrimidine compounds for use as her2 inhibitors | |
| CN116102533A (zh) | 一种芳杂环类化合物及其应用 | |
| WO2018220252A1 (es) | Derivados de piridoquinazolina eficaces como inhibidores de proteína quinasa |